Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it is evident that they share several common features. Crucial mechanisms involved in sarcopenia-nonalcoholic fatty liver disease (NAFLD) interplay are based on effects of insulin resistance, chronic infl...
Saved in:
Main Authors: | Ivana Mikolasevic, Tajana Pavic, Tajana Filipec Kanizaj, Darija Vranesic Bender, Viktor Domislovic, Zeljko Krznaric |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/8859719 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
by: Christopher G Laine, et al.
Published: (2020-01-01) -
Genetics of Keratoconus: Where Do We Stand?
by: Khaled K. Abu-Amero, et al.
Published: (2014-01-01) -
Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01) -
Inflammation and Immune Response in COPD: Where Do We Stand?
by: Nikoletta Rovina, et al.
Published: (2013-01-01) -
Extracorporeal Cardiopulmonary Resuscitation—Where Do We Currently Stand?
by: Brandon E. Ferrell, et al.
Published: (2025-01-01)